Compare BRBS & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRBS | RXST |
|---|---|---|
| Founded | 1893 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.8M | 300.5M |
| IPO Year | 2015 | 2021 |
| Metric | BRBS | RXST |
|---|---|---|
| Price | $3.58 | $5.65 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $9.78 |
| AVG Volume (30 Days) | 419.3K | ★ 1.3M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 24.78% | N/A |
| EPS Growth | ★ 135.48 | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | $111,284,000.00 | ★ $134,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.06 |
| P/E Ratio | $359.00 | ★ N/A |
| Revenue Growth | ★ 123.99 | N/A |
| 52 Week Low | $3.23 | $4.48 |
| 52 Week High | $4.79 | $13.22 |
| Indicator | BRBS | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 65.21 | 56.90 |
| Support Level | $3.24 | $5.30 |
| Resistance Level | $3.71 | $6.53 |
| Average True Range (ATR) | 0.07 | 0.34 |
| MACD | 0.03 | 0.12 |
| Stochastic Oscillator | 79.27 | 99.54 |
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, and others. It generates the majority of its revenue from commercial banking.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.